Претраживање
Приказ резултата 1-10 од 15
Cross-sectional survey on Toxoplasma gondii infection in cattle, sheep and pigs in Serbia: Seroprevalence and risk factors
(Elsevier Science Bv, Amsterdam, 2006)
Toxoplasmosis is a globally distributed zoonosis with a clinical impact in the unborn fetus and in the immunosuppressed individual. In Serbia, studies of risk factors for Toxoplasma gondii infection in humans have shown ...
Hydroxyurea induces the eNOS-cGMP pathway in endothelial cells
(Amer Soc Hematology, Washington, 2006)
Hydroxyurea is a cell-cycle-specific drug that has been used to treat myeloproliferative diseases and sickle cell anemia. We have recently shown that hydroxyurea, like nitric oxide (NO)-donor compounds, increased cGMP ...
Haemodynamic effects of no and vitamin C supplementation in SHR with acute renal failure
(Lippincott Williams & Wilkins, Philadelphia, 2006)
Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells
(Amer Soc Hematology, Washington, 2008)
Hydroxyurea, a drug widely used for treating myeloproliferative diseases, has also been approved for the treatment of sickle cell disease by raising fetal hemoglobin (HbF). We have shown that nitric oxide (NO) and the ...
Influence of microenvironmental conditions on hybridoma cell growth inside the alginate-poly-L-lysine microcapsule
(Elsevier Sci Ltd, Oxford, 2007)
A mathematical model was formulated to describe hybridoma cell growth within the alginate-poly-L-lysine (alginate-PLL) microcapsules during air-lift bioreactor cultivation. Model development was based on experimentally ...
Globin genes induction by nitric oxide of stromal cell origin
(Amer Soc Hematology, Washington, 2007)
Developmental and differential changes of gene expression in erythroid progenitor cells.
(Amer Soc Hematology, Washington, 2005)
Combined endothelin and AII blockade reduces mean arterial pressure and fails to improve postischaemic acute renal failure
(Lippincott Williams & Wilkins, Philadelphia, 2003)
Serologic rebounds after one-year-long treatment for congenital toxoplasmosis
(Lippincott Williams & Wilkins, Philadelphia, 2000)
Concentrations of IL-17 and autoantibodies in sera of patients with primary Sjogren's syndrome
(BMJ Publishing Group, London, 2007)